|
1
|
Quantitative investigations of idiotypic antibodies. I. Analysis of precipitating antibody populations.
|
J Exp Med
|
1969
|
3.10
|
|
2
|
Immunity to chlamydial infections of the eye. I. The role of circulatory and secretory antibodies in resistance to reinfection with guinea pig inclusion conjunctivitis.
|
J Immunol
|
1973
|
2.50
|
|
3
|
The role of immunoglobulin in the neutralization of trachoma infectivity.
|
J Immunol
|
1974
|
2.10
|
|
4
|
Immunity to chlamydial infections of the eye. VI. Homologous neutralization of trachoma infectivity for the owl monkey conjuctivae by eye secretions from humans with trachoma.
|
J Infect Dis
|
1973
|
1.97
|
|
5
|
Immunity to chlamydial infections of the eye. 3. Presence and duration of delayed hypersensitivity to guinea pig inclusion conjuctivitis.
|
J Immunol
|
1973
|
1.92
|
|
6
|
Quantitative investigations of idiotypic antibodies. II. Nonprecipitating antibodies.
|
J Exp Med
|
1970
|
1.63
|
|
7
|
Immunity to chlamydial infections of the eye. II. Studies of passively transferred serum antibody in resistance to infection with guinea pig inclusion conjunctivitis.
|
Infect Immun
|
1973
|
1.45
|
|
8
|
Quantitative investigations of idiotypic antibodies. 3. Persistence and variations of idiotypic specificities during the course of immunization.
|
J Exp Med
|
1970
|
1.43
|
|
9
|
Isolation and purification of a type-specific antigen from Chlamydia trachomatis propagated in cell culture utilizing molecular shift chromatography.
|
J Immunol
|
1980
|
1.41
|
|
10
|
The rightward gas vesicle operon in Halobacterium plasmid pNRC100: identification of the gvpA and gvpC gene products by use of antibody probes and genetic analysis of the region downstream of gvpC.
|
J Bacteriol
|
1993
|
1.28
|
|
11
|
Specific heterologous enhancement of immune responses. V. Isolation of a soluble enhancing factor from supernatants of specifically stimulated and allogeneically induced lymphoid cells.
|
J Immunol
|
1973
|
1.23
|
|
12
|
Characterization of an antigen secreted by Chlamydia-infected cell culture.
|
Immunology
|
1987
|
1.10
|
|
13
|
Isolation of a type-specific antigen from Chlamydia trachomatis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
|
J Immunol
|
1979
|
1.07
|
|
14
|
Separation and partial characterization of a type-specific antigen from Chlamydia trachomatis.
|
J Immunol
|
1978
|
1.05
|
|
15
|
Biosynthesis of antibody molecules with similar properties during prolonged immunization.
|
Biochemistry
|
1969
|
1.02
|
|
16
|
Oral immunization against chlamydial eye infection.
|
Invest Ophthalmol Vis Sci
|
1987
|
1.02
|
|
17
|
Stillbirth following maternal Lyme disease.
|
N Y State J Med
|
1987
|
1.01
|
|
18
|
Changes in immunoferritin labeling of Rickettsia tsutsugamushi after serial cultivation in 60Co-irradiated BHK cells.
|
Infect Immun
|
1979
|
0.94
|
|
19
|
Antigens of Chlamydia trachomatis.
|
Rev Infect Dis
|
1986
|
0.94
|
|
20
|
Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection.
|
Nat Med
|
1996
|
0.93
|
|
21
|
Examination of chlamydial glycolipid with monoclonal antibodies: cellular distribution and epitope binding.
|
Immunology
|
1991
|
0.92
|
|
22
|
Immunity to chlamydial infections of the eye. IV. Immunity in owl monkeys to reinfection with trachoma.
|
Arch Ophthalmol
|
1975
|
0.92
|
|
23
|
Concurrent neocortical borreliosis and Alzheimer's disease.
|
Hum Pathol
|
1987
|
0.90
|
|
24
|
Immune response of owl monkeys to topical vaccination with irradiated Chlamydia trachomatis.
|
J Infect Dis
|
1984
|
0.90
|
|
25
|
Specific heterologous enhancement of immune responses. VI. Partial purification of a nonspecific enhancing factor from supernates of allogeneically stimulated human lymphocyte cell lines.
|
J Exp Med
|
1974
|
0.87
|
|
26
|
Temporal arteritis associated with Borrelia infection. A case report.
|
J Clin Neuroophthalmol
|
1989
|
0.85
|
|
27
|
Neutralization of tetanus toxin by human and rabbit immunoglobulin classes and subunits.
|
Immunology
|
1977
|
0.83
|
|
28
|
Interstitial cystitis and Borrelia burgdorferi.
|
Ann Intern Med
|
1989
|
0.81
|
|
29
|
Use of an autologous antigen in the serologic testing of patients with erythema migrans of Lyme disease.
|
J Am Acad Dermatol
|
1988
|
0.81
|
|
30
|
Nonvariant antigens limited to bloodstream forms of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
|
J Protozool
|
1984
|
0.81
|
|
31
|
Purification and properties of a nucleoside triphosphate pyrophosphohydrolase from red cells of the rabbit.
|
J Biol Chem
|
1969
|
0.80
|
|
32
|
Isolation and partial characterization of an antibody enhancing factor from leukaemic owl monkey cell cultures.
|
Immunology
|
1978
|
0.78
|
|
33
|
Borrelia in the brains of patients dying with dementia.
|
JAMA
|
1986
|
0.78
|
|
34
|
Anti-idiotypic antibodies that protect cells against the action of diphtheria toxin.
|
Proc Natl Acad Sci U S A
|
1989
|
0.77
|
|
35
|
Biochemical and functional antigenic mimicry by a polyclonal anti-idiotypic antibody for chlamydial exoglycolipid antigen.
|
Pathobiology
|
1997
|
0.76
|
|
36
|
An indirect immunofluorescent test for human antibodies to tetanus toxoid using an insoluble toxoid as antigen.
|
Clin Exp Immunol
|
1975
|
0.75
|
|
37
|
Purification and properties of a factor from leukaemic T cells which non-specifically enhances the antibody response.
|
Immunology
|
1981
|
0.75
|
|
38
|
The conversion of an enhancing factor to a suppressor factor by the formation of an aggregate molecule.
|
Immunology
|
1981
|
0.75
|
|
39
|
Human fetal borreliosis, toxemia of pregnancy, and fetal death.
|
Zentralbl Bakteriol Mikrobiol Hyg A
|
1986
|
0.75
|
|
40
|
Inhibition of cholesterol side chain cleavage by active site directed antibody to corpus luteum cytochrome P-450.
|
J Biol Chem
|
1982
|
0.75
|
|
41
|
A case of crystal formation in bone marrow.
|
Clin Chem
|
1984
|
0.75
|
|
42
|
Giant cell arteritis and Borrelia infection.
|
J Clin Neuroophthalmol
|
1987
|
0.75
|